Product Information
SYSTANE 0.3% EYE GEL is a brand product labeled by Alcon Laboratories, Inc., priced at $0.9037 per GM under NDC 00065047401. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
3 mg/g
Manufacturer
Alcon Laboratories, Inc.NDC
00065047401
Classification
Brand
Dosage Form
GEL
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
HYPROMELLOSE 2910 (4000 MPA.S)Approval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
12/15/2012
Price Statistics
The NADAC for SYSTANE 0.3% EYE GEL has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 26.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9037 per GM |
|---|---|
| All-time high | $1.0132 (Sep 16, 2020) |
| All-time low | $0.2713 (Aug 23, 2017) |
| 52-week high | $0.9173 |
| 52-week low | $0.8389 |
| Median price | $0.7823 |
| Average price | $0.7921 |
| Largest weekly change | +167.3% (Aug 30, 2017) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the hypromellose market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alcon Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hypromellose market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SYSTANE 0.3% EYE GEL?
The current National Average Drug Acquisition Cost (NADAC) for SYSTANE 0.3% EYE GEL, manufactured by Alcon Laboratories, Inc., is $0.9037 per GM (NDC 00065047401), effective Sep 30, 2026.
How has the price of SYSTANE 0.3% EYE GEL changed over time?
Over the history we have for it, the NADAC for SYSTANE 0.3% EYE GEL has risen 26.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SYSTANE 0.3% EYE GEL?
Since Nov 28, 2013, the NADAC for SYSTANE 0.3% EYE GEL has ranged from a low of $0.2713 (Aug 23, 2017) to a high of $1.0132 (Sep 16, 2020), with a median of $0.7823 per GM.
Are there cheaper alternatives to SYSTANE 0.3% EYE GEL?
No other NADAC-published product currently shares the active ingredient and strength of SYSTANE 0.3% EYE GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SYSTANE 0.3% EYE GEL?
SYSTANE 0.3% EYE GEL (NDC 00065047401) is labeled by Alcon Laboratories, Inc., and CMS classifies it as a brand product.